-
Viremia does not independently predict cardiovascular disease in people with HIV: a RESPOND cohort study Open Forum Infectious Diseases. Elvstam O, Ryom L, Neesgaard B, Tau L, Günthard H F, Zangerle R, Vehreschild J J, Wit F, Sönnerborg A, Kovari H, Abutidze A, Petoumenos K, Jaschinski J, Hosein S, Bogner J, Grabmeier-Pfistershammer K, Garges H, Rooney J, Young L, Law M, Kirk O for the RESPOND Study Group.
Accepted for publication in Open Forum Infectious Diseases 2025.
-
A simple tool to evaluate the effectiveness of 1 HIV care for settings with gaps in data availability 2 (ESTIHIV). Raben D, Jakobsen M L, Trajanovska J, Kowalska J, Vassilenko A, Dragas S, Harxhi A, Dragovic G J, Jaschinski N, Neesgaard B, Hjorth-Larsen K, Garges H, Gallant J, Lundgren J D, Philips A, Cambiano V, Yazdanpanah Y and Mocroft A.
Accepted for publication in PLOS One 2025.
-
Tuberculosis in people with HIV across Europe from 2012-2022: incidence rates, risk factors, and regional differences in a multicentre cohort study. Kraef C, Roen A, Podlekareva D, Bakowska E, Nemeth J, Knappik M, Payen M-C, Wit F, Mussini C, d’Arminio Monforte11 A, Castagna A, Chkhartishvili N, Neesgaard B, Jaschinski1 N, Volny Anne A, Borodulina E, Ballief M, Wallner E, Israelski D, Garges H, Mocroft A, Kirk O and the RESPOND Study Group.
Accepted for publication in European Respiratory Journal 2025.